Search

everythinglearnresearchcommunity

for

Search:↓

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The method can measure vitamin B3 levels in human hair accurately.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Post-finasteride syndrome's existence is uncertain; more research needed.

Maidenhair fern extract reduced anxiety and depression in rats and may work due to its antioxidant and anti-inflammatory properties.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Chitosan nanoparticles are promising for sustained caffeine delivery through the skin.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Testosterone is crucial for development, growth, and various body functions in mammals.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Oral dutasteride improves hair growth, reduces hair loss, and is safe for most patients.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hair loss can cause serious mental health problems and treating it requires a team of experts.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

Charnoly bodies could be a marker for cell damage, and certain nutrients and proteins might prevent them, potentially helping with brain diseases and cancer.

Dermoscopy helps diagnose unusual skin lesions like osteonevus of Nanta and can prevent misdiagnosis of serious conditions.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Psychotropic drugs can cause hair loss or excessive hair growth.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.